Jennifer Hardesty
The future of our professions
March 18, 2015ASCP's upcoming forum is designed for all post-acute care stakeholders involved in care transitions: consultant pharmacists; health care executives; and managers from long-term care facilities, pharmacy operations, home care, hospitals, and accountable care organizations.
Hardesty promoted at Remedi
September 12, 2014Jennifer L. Hardesty, PharmD, FASCP, has been named the chief clinical officer at Remedi SeniorCare. She will be responsible for the "continued development and implementation of the clinical programs for the company, as well as providing direction and standard reporting tools for Remedi's consultant pharmacists," the company said.
McKnight's webcast to take providers to (DAB) court
June 23, 2014Providers will get a close look at and understanding of how they can challenge survey findings before an administrative law judge at a McKnight's webinar. "So you want your day in court: Lessons learned form the Departmental Appeals Board" will start at 1 p.m. July 18. The free, hour-long event will include a speaker who will discuss his experiences as a surveyor who testified in cases like the ones that will be simulated during the broadcast. Attendees also can "rule" as to the final outcome.
Compounding pharmacies: Are your residents safe?
January 11, 2013Last year's tragic and deadly meningitis outbreak left many confused about the differences between compounding pharmacies versus others and what compounded medicine is, as well as the way each are regulated. The information below aims to provide clarity about the terms and their respective practices.
Under the microscope: The ever-increasing scrutiny of antipsychotics in LTC
June 28, 2012Facilities need to prepare for the increased scrutiny that surveyors will have on dementia residents taking antipsychotics. While antipsychotics may be required for some residents, a full-fledged review of all antipsychotic use in your facility may be warranted, and problematic behaviors must be documented.
